Genome engineering is utilized for the changes that are to be done in the DNA of a cell or an organism. The technique involves cutting DNA sequences for the addition or removing the DNA in the genome. The changes in the genome are done for the required characteristics of the cell. Genome editing is done for the research purpose, the treatment of the diseases, and the biotechnological purpose.
The "Global Genetic Engineering Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Genetic Engineering market with detailed market segmentation by technology, application, end user, and geography. The report provides key statistics on the market status of the leading Genetic Engineering analysis market players and offers key trends and opportunities in the market.
- Based on technology, the global genetic engineering analysis market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies.
- On the basis of application, the market is segmented into cell line engineering, genetic engineering, and diagnostics and therapeutics.
- On the basis of end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.
- Rising government funding and growth in the number of genomics projects
- Expanding application areas of genomics
- Introduction of CRISPR-Cas9
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Genetic Engineering market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the market in these regions.
IMPACT OF COVID-19 ON GENETIC ENGINEERING MARKET
In the first half of 2020, COVID-19 hasn't affected the biotech market landscape. There is also the potential for negative impacts of both a medium- and longer-term nature on R&D and manufacturing activities, as well as delay on projects/programs. As encouraging emerge for mRNA, other platforms (such as cell and gene therapies are likely to drive the market growth. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
The report covers key developments in the Genetic Engineering market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Genetic Engineering market are anticipated to lucrative growth opportunities in the future with the rising demand for Genetic Engineering Analysis market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Genetic Engineering market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Integrated DNA Technologies, Inc
- Thermo Fisher Scientific Inc
- Horizon Discovery Group Plc
- Merck KGaA
- Transposagen Biopharmaceuticals Inc
- New England Biolabs
- Genscript Biotech Corporation
- Lonza Group
- Origene Technologies, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.